The Treatment of Hypertension with Hydrochlorothiazide: A Comparison with Reserpine

Abstract

Get full access to this article

View all access options for this article.

References

Baer

J. E.

Leidy

Brooks

A. V.

(1957). Physiological disposition of chlorothiazide (6-chloro-7-sulfamyl-1, 2, 4-benzothiadiazine-1, 1-dioxide) a saluretic-diuretic agent. Fed. Proc., 16, 278

Bayer

K. H.

Baer

J. E.

Russo

H. F.

Haim-Bach

(1957). Chlorothiazide (6-chloro-7-sulfamyl-1, 2, 4-benzothiadiazine-1, 1-dioxide) : The enhancement of sodium chloride excretion. Fed. Proc., 16, 282

Calesnick

(1959). Factors associated with the hypotensive action of hydrochlorothiazide. Clin. Med., 6, 613

Dollery

C. T.

Harington

Kaufmann

(1959). The mode of action of chlorothiazide in hypertension: With special reference to potentiation of ganglion-blocking agents. Lancet, 1, 1215

Fife

Paton

J. P. J.

Whyte

W. G.

(1958). Treatment of hypertension in out-patients: The initial assessment and the effect of reserpine. Scot. med. J., 3, 165

Fife

Paton

J. P. J.

Whyte

W. G.

(1959). Treatment of hypertension in out-patients: The effect of pentolinium. Scot. med. J., 4, 242

Fleming

P. R.

Zilva

Bayliss

R. I. S.

Pirkis

(1959). Hydrochlorothiazide: A comparison with chlorothiazide. Lancet, 1, 1218

Ford

R. V.

Moyer

J. H.

Spurr

C. L.

(1957). Clinical and laboratory observations on chlorothiazide, an orally effective non-mercurial diuretic agent. A. M. A. Arch. int. Med., 100, 582

Freis

E. D.

Wilson

I. M.

(1957). Potentiating effect of chlorothiazide (Diuril) in combination with antihypertensive agents. Preliminary report. Med. Ann. D. C., 26, 468

10.

Freis

E. D.

Wanco

Wilson

I. M.

Parrish

A. E.

(1958). Treatment of essential hypertension with chlorothiazide (Diuril). Its use alone and combined with other anti-hypertensive agents. J. Amer. med. Ass., 166, 137

11.

Heider

Dennis

Moyer

J. H.

(1958). Chlorothiazide potentiation of ganglionic blockade in patients with hypertension. Ann. N.Y. Acad. Sci., 71, 456

12.

Hejmancik

M. R.

Herrmann

G. R.

Kroetz

F. W.

(1959). The effects of SU 5879 (Esidrex) in congestive heart failure and hypertension: A clinical evaluation. Amer. Heart J., 57, 490

13.

Herrmann

G. R.

Hejtmancik

M. R.

Kroetz

F. W.

(1958). Clinical evaluation of SU-5879 (Esidrex), a new oral sulphonamide diuretic: Preliminary report. Tex. St. J. Med., 54, 854

14.

Losse

Wehmeyer

Strobel

Wesselkock

(1959). Untersuchungen mit einem neuen salidiuretikum. Münch. med. Wschr., 101, 677

15.

Moyer

J. H.

(1958). Chlorothiazide in hypertension (discussion at conference). Ann. N.Y. Acad. Sci., 71, 475

16.

Moyer

J. H.

Ford

R. V.

Spurr

C. L.

(1957). Pharmacodynamics of chlorothiazide (Diuril), an orally effective, non-mercurial diuretic agent. Proc. Soc. exp. Biol. (N.Y.), 95, 529

17.

Moyer

J. H.

Fuchs

Irie

Bodi

(1959). Some observations on the pharmacology of hydrochlorothiazide. Amer. J. Cardiol., 3, 113

18.

Novello

F. C.

Sprague

J. M.

(1957). Benzothiadiazine dioxides as novel diuretics. J. Amer. chem. Soc., 79, 2028

19.

Richterich

(1959). Experimentell-Klinische Untersuchungen über Hydrochlorothiazid (Esidrex), ein neues Diuretisch Wirksames Sulfonamid. Klin. Wschr., 37, 355

20.

Richterich

Spring

Thönen

(1959). Klinische erfahrungen mit hydrochlorothiazid, einem neuen, oral verabreichbaren sulphonamid diureticum. Schweiz. med. Wschr., 89, 353

21.

Sackner

M. A.

Wallack

A. A.

Bellet

(1959). The diuretic effects of hydrochlorothiazide in congestive heart failure, cirrhosis, chronic renal disease and hypertension: Preliminary report based on a study of 28 cases. Amer. J. med. Sc., 237, 575

22.

Stevens

De Werner

L. H.

Halamandaris

Ricca

(1958). Dihydrobenzothiadiazine dioxides with potent diuretic effect. Experimentia, 14, 463